Groupe Bruxelles Lambert (GBLBY) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free GBLBY Stock Alerts $7.44 +0.22 (+3.05%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendShort InterestStock AnalysisChartDividendShort Interest Groupe Bruxelles Lambert Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$766.00Short Interest Ratio / Days to Cover0.3Last Record DateMarch 31, 2024Today's Trading Volume342 sharesAverage Trading Volume1,428 sharesToday's Volume Vs. Average24% Short Selling Groupe Bruxelles Lambert ? Sign up to receive the latest short interest report for Groupe Bruxelles Lambert and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGBLBY Short Interest Over TimeGBLBY Days to Cover Over TimeGBLBY Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Groupe Bruxelles Lambert Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024100 shares $766.00 No ChangeN/A0.3 $7.66 12/31/2023100 shares $855.00 No ChangeN/A0.1 $8.55 10/31/2023400 shares $2,966.00 No ChangeN/A0.1 $7.42 8/31/2023100 shares $867.00 -93.3%N/A0 $8.67 8/15/20231,500 shares $12,150.00 No ChangeN/A0.4 $8.10 6/30/2023200 shares $1,520.00 No ChangeN/A0.1 $7.60 Get the Latest News and Ratings for GBLBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Groupe Bruxelles Lambert and its competitors with MarketBeat's FREE daily newsletter. 5/15/20231,600 shares $12,224.00 +100.0%N/A0.9 $7.64 4/30/2023800 shares $7,512.00 +300.0%N/A0.5 $9.39 4/15/2023200 shares $1,762.00 No ChangeN/A0.1 $8.81 3/15/2023400 shares $3,112.00 No ChangeN/A0.1 $7.78 12/15/20221,600 shares $13,008.00 No ChangeN/A0.3 $8.13 11/30/20221,600 shares $13,088.00 -82.6%N/A0.3 $8.18 11/15/20229,200 shares $76,937.76 -25.8%N/A2.5 $8.36 10/31/202212,400 shares $97,960.00 +629.4%N/A0.7 $7.90 10/15/20221,700 shares $14,450.00 No ChangeN/A0.1 $8.50 9/15/20229,800 shares $92,120.00 No ChangeN/A0 $9.40 8/15/202214,900 shares $178,651.00 +91.0%N/A0.5 $11.99 7/31/20227,800 shares $69,537.00 +95.0%N/A0.3 $8.92 7/15/20224,000 shares $32,480.00 -41.2%N/A0.1 $8.12 6/30/20226,800 shares $57,188.00 -70.8%N/A0.2 $8.41 6/15/202223,300 shares $196,885.00 +80.6%N/A0.8 $8.45 5/31/202212,900 shares $114,745.50 +21.7%N/A0.7 $8.90 5/15/202210,600 shares $92,723.50 +6.0%N/A0.9 $8.75 4/30/202210,000 shares $98,700.00 +354.6%N/A0.8 $9.87 4/15/20222,200 shares $22,308.00 -75.8%N/A0.2 $10.14 3/31/20229,100 shares $94,458.00 +203.3%N/A0.8 $10.38 3/15/20223,000 shares $30,150.00 +3.5%N/A0.1 $10.05 2/28/20222,900 shares $31,842.00 No ChangeN/A0.2 $10.98 1/31/20225,500 shares $59,290.00 +44.7%N/A0.4 $10.78 1/15/20223,800 shares $43,320.00 +192.3%N/A0.7 $11.40 12/31/20211,300 shares $14,872.00 -87.5%N/A0.1 $11.44 12/15/202110,400 shares $113,464.00 +372.7%N/A0.8 $10.91 11/30/20212,200 shares $24,112.00 +340.0%N/A0.2 $10.96 11/15/2021500 shares $6,000.00 -91.2%N/A0 $12.00 10/29/20215,700 shares $66,234.00 -39.4%N/A0.4 $11.62 10/15/20219,400 shares $106,596.00 +1,780.0%N/A0.4 $11.34 9/30/2021500 shares $5,510.00 -16.7%N/A1.7 $11.02 9/15/2021600 shares $6,900.00 -53.9%N/A0.2 $11.50 8/31/20211,300 shares $15,041.00 +18.2%N/A0.5 $11.57 8/13/20211,100 shares $12,969.00 +10.0%N/A0.3 $11.79Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> GBLBY Short Interest - Frequently Asked Questions What is Groupe Bruxelles Lambert's current short interest? Short interest is the volume of Groupe Bruxelles Lambert shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 100 shares of GBLBY short. Learn More on Groupe Bruxelles Lambert's current short interest. Is Groupe Bruxelles Lambert's short interest increasing or decreasing? Groupe Bruxelles Lambert saw a increase in short interest in March. As of March 31st, there was short interest totaling 100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Groupe Bruxelles Lambert stock? Short selling GBLBY is an investing strategy that aims to generate trading profit from Groupe Bruxelles Lambert as its price is falling. GBLBY shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Groupe Bruxelles Lambert? A short squeeze for Groupe Bruxelles Lambert occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GBLBY, which in turn drives the price of the stock up even further. How often is Groupe Bruxelles Lambert's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GBLBY, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: 3i Group Short Squeeze 3i Group Short Squeeze AB Industrivärden (publ) Short Squeeze AB Industrivärden (publ) Short Squeeze Aberdeen International Short Squeeze Abrdn Australia Equity Fund Short Squeeze Abrdn Global Dynamic Dividend Fund Short Squeeze abrdn Global Premier Properties Fund Short Squeeze Abrdn Healthcare Opportunities Fund Short Squeeze Abrdn Income Credit Strategies Fund Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GBLBY) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace